Symbol="ADVM"
AssetType="Common Stock"
Name="Adverum Biotechnologies Inc"
Description="Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops candidate gene therapy products to treat eye and rare diseases. The company is headquartered in Redwood City, California."
CIK="1501756"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="1035 O'BRIEN DRIVE, MENLO PARK, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="170978000"
EBITDA="-135722000"
PERatio="None"
PEGRatio="0"
BookValue="1.569"
DividendPerShare="0"
DividendYield="0"
EPS="-1.62"
RevenuePerShareTTM="0.036"
ProfitMargin="0"
OperatingMarginTTM="-39.56"
ReturnOnAssetsTTM="-0.261"
ReturnOnEquityTTM="-0.661"
RevenueTTM="3600000"
GrossProfitTTM="-81681000"
DilutedEPSTTM="-1.62"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.7"
AnalystTargetPrice="3.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="3419.85"
PriceToBookRatio="0.302"
EVToRevenue="3700.64"
EVToEBITDA="0.229"
Beta="0.806"
num_52WeekHigh="1.82"
num_52WeekLow="0.531"
num_50DayMovingAverage="1.17"
num_200DayMovingAverage="0.859"
SharesOutstanding="100575000"
DividendDate="None"
ExDividendDate="None"
symbol="ADVM"
open="1.56"
high="1.79"
low="1.50"
price="1.70"
volume="1871728.00"
latest_trading_day="2023-07-07"
previous_close="1.54"
change="0.16"
change_percent="10.3896%"
aroon_positive_momentum_days="92"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Trending Low"
value_analysis="Bearish Trend"
Aroon_change="FALSE"
Aroon_momentum="92"
Volume_recent_avg="437259"
Change_recent_avg="0.01"
Delta_recent_avg="0.08"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="1.07"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="92"
Aroon_momentum_negative="8"
image_negative_thumbnail_id_1="513"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0092.jpeg"
image_negative_thumbnail_id_2="499"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0106.jpeg"
image_neutral_thumbnail_id_1="552"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_neutral_thumbnail_id_2="598"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0001.jpeg"
image_positive_thumbnail_id_1="975"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0137.jpeg"
image_positive_thumbnail_id_2="1166"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Negative_0187.jpeg"
image_professor_thumbnail_id_1="1200"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
image_professor_thumbnail_id_2="1184"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
